Monitoring therapeutic efficacy in breast carcinomas
- PMID: 16733676
- DOI: 10.1007/s00330-006-0317-z
Monitoring therapeutic efficacy in breast carcinomas
Abstract
The aim of imaging during and after neoadjuvant therapy is to document and quantify tumor response: has the tumor size been accurately measured? Certainly, the most exciting information for the oncologists is: can we identify good or nonresponders, and can we predict the pathological response early after the initiation of treatment? This review article will discuss the role and the performance of the different imaging modalities (mammography, ultrasound, magnetic resonance imaging and FDG-PET imaging) for evaluating this therapeutic response. It is important to emphasize that, at this time, clinical examination and conventional imaging (mammography and ultrasound) are the only methods recognized by the international criteria. Magnetic resonance imaging and FDG-PET imaging are very promising for predicting the response early after the initiation of neoadjuvant chemotherapy.
Similar articles
-
Assessment of residual tumour by FDG-PET: conventional imaging and clinical examination following primary chemotherapy of large and locally advanced breast cancer.Br J Cancer. 2010 Jan 5;102(1):35-41. doi: 10.1038/sj.bjc.6605427. Epub 2009 Nov 17. Br J Cancer. 2010. PMID: 19920815 Free PMC article. Clinical Trial.
-
Impact of Pretreatment Combined (18)F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Staging on Radiation Therapy Treatment Decisions in Locally Advanced Breast Cancer.Int J Radiat Oncol Biol Phys. 2015 Sep 1;93(1):111-7. doi: 10.1016/j.ijrobp.2015.05.012. Epub 2015 May 15. Int J Radiat Oncol Biol Phys. 2015. PMID: 26279029
-
A comparison of 18F-FDG gamma camera PET, mammography and ultrasonography in demonstrating primary disease in locally advanced breast cancer.Nucl Med Commun. 2004 Jul;25(7):721-5. doi: 10.1097/01.mnm.0000130239.76326.ca. Nucl Med Commun. 2004. PMID: 15208500 Clinical Trial.
-
Response to therapy in breast cancer.J Nucl Med. 2009 May;50 Suppl 1:55S-63S. doi: 10.2967/jnumed.108.057240. Epub 2009 Apr 20. J Nucl Med. 2009. PMID: 19380410 Review.
-
Imaging surveillance of patients with breast cancer after primary treatment: current recommendations.Korean J Radiol. 2015 Mar-Apr;16(2):219-28. doi: 10.3348/kjr.2015.16.2.219. Epub 2015 Feb 27. Korean J Radiol. 2015. PMID: 25741186 Free PMC article. Review.
Cited by
-
Imaging and cancer: a review.Mol Oncol. 2008 Aug;2(2):115-52. doi: 10.1016/j.molonc.2008.04.001. Epub 2008 May 10. Mol Oncol. 2008. PMID: 19383333 Free PMC article. Review.
-
The Role of MRI in Breast Cancer and Breast Conservation Therapy.Cancers (Basel). 2024 Jun 1;16(11):2122. doi: 10.3390/cancers16112122. Cancers (Basel). 2024. PMID: 38893241 Free PMC article. Review.
-
Preliminary study of early response to neoadjuvant chemotherapy after the first cycle in breast cancer: comparison of 1H magnetic resonance spectroscopy with diffusion magnetic resonance imaging.Jpn J Radiol. 2010 Feb;28(2):101-9. doi: 10.1007/s11604-009-0391-7. Epub 2010 Feb 26. Jpn J Radiol. 2010. PMID: 20182844
-
Surgical Planning after Neoadjuvant Treatment in Breast Cancer: A Multimodality Imaging-Based Approach Focused on MRI.Cancers (Basel). 2023 Feb 24;15(5):1439. doi: 10.3390/cancers15051439. Cancers (Basel). 2023. PMID: 36900231 Free PMC article. Review.
-
Optical imaging of breast cancer oxyhemoglobin flare correlates with neoadjuvant chemotherapy response one day after starting treatment.Proc Natl Acad Sci U S A. 2011 Aug 30;108(35):14626-31. doi: 10.1073/pnas.1013103108. Epub 2011 Aug 18. Proc Natl Acad Sci U S A. 2011. PMID: 21852577 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical